Skip to content

Psilocybin and psychedelic-assisted therapy: all studies

Page 5 of 26: studies 41 to 50 of 252, newest first. Back to the psilocybin and psychedelic-assisted therapy overview

Research

Psilocybin-assisted psychotherapy in adults with depression – A literature review

Progress in Neuro-Psychopharmacology and Biological Psychiatry September 24, 2025 Marie Celine Dorczok, Gloria Mittmann, Thomas Ettl et al. 2 citations

PAP combined with structured psychological support shows sustained reductions in depressive symptoms for treatment-resistant depression and major depressive disorder. Higher doses generally yield stronger benefits. While PAP holds significant potential as a holistic treatment, methodological limitations, such as heterogeneity in study designs, inconsistent levels of psychological support and...

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction September 20, 2025 Elizabeth Knock, Krista J. Siefried, Gillinder Bedi et al. 4 citations

Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study. Setting Outpatient public stimulant treatment program at St. Vincent's Hospital, Sydney,...

Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective.

Journal of Eating Disorders September 2, 2025 Elena Koning, Riccardo Miceli Mcmillan, Aaron Keshen et al. 3 citations

Psychedelic-assisted therapy (PAT) is an emerging intervention in psychiatry, for which there is preliminary evidence for effectiveness in eating disorders (EDs). The subjective psychedelic experience is considered an important driver of positive outcomes following PAT; however, conventional study design approaches often overlook many of the nuances inherent to the experience. Consequently,...

Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

Psychoactives September 1, 2025 M Mercier, Cédric Mabilais, Vasileios Chytas et al.

Psychedelic substances have experienced a resurgence of clinical interest in recent years, particularly for their promising effects in the treatment of psychiatric disorders such as depression and anxiety. While evidence regarding their role in chronic pain management remains limited, emerging studies suggest potential therapeutic benefits. This case report describes a patient with persistent...

Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial

General Hospital Psychiatry August 12, 2025 Margaret Ross, Ravi Iyer, M.l. Williams et al. 13 citations

Psilocybin-assisted psychotherapy appears safe and may offer durable relief from depression and anxiety in individuals with a life-threatening illness.

DOI: 10.1016/j.genhosppsych.2025.08.001 (opens in new tab) Psilocybin Anxiety Randomized controlled trial Psychotherapist +3

A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy

General Hospital Psychiatry August 5, 2025 Jennie Hultgren, Matthias H Hafsteinsson, Joel Gruneau Brulin 13 citations

Our findings did not support that the amount of therapy hours influence depressive outcomes in PAT. However, this interpretation should be made with caution due to small sample sizes, heterogeneity, and poor reporting of the therapeutic component across studies. Future research should apply greater methodological rigor and standardized reporting of therapy to clarify its role in PAT.

DOI: 10.1016/j.genhosppsych.2025.07.020 (opens in new tab) Psilocybin Meta-analysis Pharmacotherapy Psychotherapist +1

519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL

The International Journal of Neuropsychopharmacology August 1, 2025 N Acevdo, David Castle, Susan L. Rossell

Abstract Background Obsessive compulsive disorder (OCD), body dysmorphic disorder (BDD), and anorexia nervosa (AN) are some of the most debilitating and chronic mental health conditions, with impairments across multiple domains of functioning, leading to poor quality of life and well-being. These conditions share overlapping psychopathological determinants in terms of cognitive-behavioural...

DOI: 10.1093/ijnp/pyaf052.084 (opens in new tab) Full text (opens in new tab) Psilocybin Anorexia nervosa Body dysmorphic disorder Obsessive compulsive +2

An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 25, 2025 Kiana Askariyan, Mohammad Taghi Joghataei, Samaneh Dehghan et al. 9 citations

The resurgence of psychedelic-assisted psychotherapy marks a pivotal evolution in mental health treatment, challenging traditional paradigms by integrating compounds such as psilocybin, LSD, MDMA, and ketamine into clinical practice. Historically marginalized due to regulatory and societal concerns, these agents are now gaining recognition for their unique neurobiological mechanisms and...

Perturbing whole‐brain models of brain hierarchy: An application for depression following pharmacological treatment

Annals of the New York Academy of Sciences July 21, 2025 Marcel Socoró-garrigosa, Yonatan Sanz Perl, Morten L. Kringelbach et al. 3 citations

Abstract Determining the scale of neural representations is a central challenge in neuroscience. While localized representations have traditionally dominated, evidence suggests information is also encoded in distributed, hierarchical networks. Recent research indicates that the hierarchy of causal influences shaping functional patterns serves as a signature of distinct brain states, with...